Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma

Clinical Cancer Research

Volumn 12, Issue 16, 2006, Pages 4851-4858

  Wang, Xiao Song ^a,b   Zhang, Zheng ^a   Wang, Hong Cheng ^b   Cai, Jian Liang ^a   Xu, Qing Wen ^b   Li, Meng Qiang ^a   Chen, Yi Cheng ^a   Qian, Xiao Ping ^b   Lu, Tian Jing ^a   Yu, Li Zhang ^a   Zhang, Yu ^b   Xin, Dian Qi ^a   Na, Yan Qun ^a   Chen, Wei Feng ^b  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENTARY DNA; PROTEIN UCA 1; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LABORATORY TEST; MICROARRAY ANALYSIS; PELVIS CANCER; PRIORITY JOURNAL; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; SERIAL ANALYSIS OF GENE EXPRESSION; UPREGULATION; URETER CANCER; URINARY TRACT DISEASE;

CARCINOMA, TRANSITIONAL CELL; CHROMOSOME MAPPING; DNA, COMPLEMENTARY; EXPRESSED SEQUENCE TAGS; GENETIC MARKERS; HUMANS; POLYMERASE CHAIN REACTION; RNA, UNTRANSLATED; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 33748337949     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-06-0134     Document Type: Article

References (34)

1. Zhang W, Xiang YB, Liu ZW, et al. [Trends analysis of common urologic neoplasm incidence of elderly people in Shanghai, 1973-1999]. Ai Zheng 2004;23:555-8.
2. Messing EM. Urothelial tumors of the urinary tract. In: Walsh PC, editor. Campbell's urology. 8th ed. Philadelphia: W.B. Saunders; 2002.
3. van Rhijn BW, van der Poel HG, van der Kwast TH. Urine markers for bladder cancer surveillance: a systematic review. Eur Urol 2005;47:736-48.
4. Chao D, Pantuck AJ, Zisman A, Belldegrun AS. Bladder cancer 2000: molecular markers for the diagnosis of transitional cell carcinoma. Rev Urol 2001;3:85-93.
5. Reis EM, Ojopi EP, Alberto FL, et al. Large-scale transcriptome analyses reveal new genetic marker candidates of head, neck, and thyroid cancer. Cancer Res 2005;65:1693-9.
6. Chen Y, Miller C, Mosher R, et al. Identification of cervical cancer markers by cDNA and tissue microarrays. Cancer Res 2003;63:1927-35.
7. Takahashi M, Yang XJ, Sugimura J, et al. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers. Oncogene 2003;22:6810-8.
8. Loging WT, Lal A, Siu IM, et al. Identifying potential tumor markers and antigens by database mining and rapid expression screening. Genome Res 2000;10:1393-402.
9. Smith B, Selby P, Southgate J, Pittman K, Bradley C, Blair GE. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 1991;338:1227-9.
10. Eissa S, Kenawy G, Swellam M, El-Fadle AA, Abd El-Aal AA, El-Ahmady O. Comparison of cytokeratin 20 RNA and angiogenin in voided urine samples as diagnostic tools for bladder carcinoma. Clin Biochem 2004;37:803-10.
11. Singer G, Rebmann V, Chen YC, et al. HLA-G is a potential tumor marker in malignant ascites. Clin Cancer Res 2003;9:4460-4.
12. Cheung IY, Cheung NK. Molecular detection of GAGE expression in peripheral blood and bone marrow: utility as a tumor marker for neuroblastoma. Clin Cancer Res 1997;3:821-6.
13. Okada Y, Fujiwara Y, Yamamoto H, et al. Genetic detection of lymph node micrometastases in patients with gastric carcinoma by multiple-marker reverse transcriptase-polymerase chain reaction assay. Cancer 2001;92:2056-64.
14. Palmieri G, Strazzullo M, Ascierto PA, Satriano SM, Daponte A, Castello G. Polymerase chain reaction-based detection of circulating melanoma cells as an effective marker of tumor progression. Melanoma Cooperative Group. J Clin Oncol 1999;17:304-11.
15. Shariat SF, Kattan MW, Erdamar S, et al. Detection of clinically significant, occult prostate cancer metastases in lymph nodes using a splice variant-specific rt-PCR assay for human glandular kallikrein. J Clin Oncol 2003;21:1223-31.
16. Ogawa H, Tamaki H, Ikegame K, et al. The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia. Blood 2003;101:1698-704.
17. Jern P, Sperber GO, Ahlsen G, Blomberg J. Sequence variability, gene structure, and expression of full-length human endogenous retrovirus H. J Virol 2005;79:6325-37.
18. Kozak M. Interpreting cDNA sequences: some insights from studies on translation. Mamm Genome 1996;7:563-74.
19. Wang X, Zhao H, Xu Q, et al. HPtaa database-potential target genes for clinical diagnosis and immunotherapy of human carcinoma. Nucleic Acids Res 2006;34:D607-12.
20. Synthesis of Gag and Gag-Pro-Pol proteins. In: Coffin JM, Hughes SH, Varmus HE, editors. Retroviruses. New York: Cold Spring Harbor Laboratory Press; 1997.
21. Mangeney M, Pothlichet J, Renard M, Ducos B, Heidmann T. Endogenous retrovirus expression is required for murine melanoma tumor growth in vivo. Cancer Res 2005;65:2588-91.
22. Galli UM, Sauter M, Lecher B, et al. Human endogenous retrovirus rec interferes with germ cell development in mice and may cause carcinoma in situ, the predecessor lesion of germ cell tumors. Oncogene 2005;24:3223-8.
23. Armbruester V, Sauter M, Krautkraemer E, et al. A novel gene from the human endogenous retrovirus K expressed in transformed cells. Clin Cancer Res 2002;8:1800-7.
24. Ting CN, Rosenberg MP, Snow CM, Samuelson LC, Meisler MH. Endogenous retroviral sequences are required for tissue-specific expression of a human salivary amylase gene. Genes Dev 1992;6:1457-65.
25. Feuchter-Murthy AE, Freeman JD, Mager DL. Splicing of a human endogenous retrovirus to a novel phospholipase A2 related gene Nucleic Acids Res 1993;21:135-43.
26. de Parseval N, Alkabbani H, Heidmann T. The long terminal repeats of the HERV-H human endogenous retrovirus contain binding sites for transcriptional regulation by the Myb protein. J Gen Virol 1999;80:841-5.
27. Cheng YH, Richardson BD, Hubert MA, Handwerger S. Isolation and characterization of the human syncytin gene promoter. Biol Reprod 2004;70:694-701.
28. Okegawa T, Kinjo M, Hone S, Nutahara K, Higashihara E. Detection of mucin 7 gene expression in exfoliated cells in urine from patients with bladder tumor. Urology 2003;62:182-6.
29. Retz M, Lehmann J, Amann E, Wullich B, Roder C, Stockle M. Mucin 7 and cytokeratin 20 as new diag nostic urinary markers for bladder tumor. J Urol 2003;169:86-9.
30. Fukui T, Nonomura N, Tokizane T, et al. Clinical evaluation of human telomerase catalytic subunit in bladder washings from patients with bladder cancer. Mol Urol 2001;5:19-23.
31. Wacharapluesadee S, Hemachudha T. Nucleic-acid sequence based amplification in the rapid diagnosis of rabies. Lancet 2001;358:892-3.
32. Loens K, Ursi D, Ieven M, et al. Detection of Mycoplasma pneumoniae in spiked clinical samples by nucleic acid sequence-based amplification. J Clin Microbiol 2002;40:1339-45.
33. Jordan HL, Scappino LA, Moscardini M, Pistello M. Detection of feline immunodeficiency virus RNA by two nucleic acid sequence based amplification (NASBA) formats. J Virol Methods 2002;103:1-13.
34. Bostwick DG, Gould VE, Qian J, Susani M, Marberger M. Prostate cancer detected by uPM3: radical prostatectomy findings. Mod Pathol 2006;19:630-3.